Pregnancy and fertility rapid tests are point of care tests used to qualitatively detect the presence of reproductive hormones, such as Follicle Stimulating Hormone (FSH), Luteinising Hormone (LH) and Human Chorionic Gonadotropin (hCG) hormone. Fertility rapid test kits can help find the exact day of ovulation or confirm the presence of menopause in women, while in males, they are used to detect the sperm count. These tests require small amount of blood or urine sample, depending upon the type of device being used; these devices work on colour changing immunoassay techniques. The global fertility and pregnancy rapid test kits market has been segmented on the basis of product type, test type, distribution channels, and region.
Market Value and Forecast
The global fertility and pregnancy rapid test kits market has been estimated to be valued at US$ 1,029.1 Mn in 2015, and is expected to expand at a 4.1% CAGR over the forecast period (2016-2026).
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-607
Growth of the global fertility and pregnancy market is mainly driven by rising demand for fast and self-contained tests, growing incidence of infertility and gynaecological disorders, availability of decentralised diagnostic tests over time-consuming laboratory tests, and increasing first-time pregnancy age. Technological advancements and attractive product features such as smartphone app connectivity are also driving adoption of fertility and pregnancy rapid test kits.
However, paradox of choice due to availability of too many options in the market, low adoption of these products in countries having inherent potential, and device related issues and controversies can impede growth of the market.
Premier players in this market are employing strategies of creating alliances with e-commerce partners and maintaining distribution agreements with strong local players in regions such as Western Europe and APEJ to consolidate their position.
Market Segmentation By Product
Based on product type, the market has been segmented into pregnancy rapid test kits and fertility rapid test kits. Pregnancy rapid test kits product type segment is further classified as line-indicator devices (further sub-segmented into strip/dip sticks, mid-stream devices and cassettes) and digital devices, whereas, fertility rapid test kits product type segment consists of line-indicator devices and digital devices. In terms of value, pregnancy test kits segment is estimated to account for more than 55% market share in global fertility and pregnancy rapid test kits market, by 2026 end.
Market Segmentation By Test Type
On the basis of test type, the market has been segmented into LH urine test, FSH urine test, hCG blood test and hCG urine test. hCG urine test segment accounted for highest market share of 42.8% in 2015 and is expected to gain the market share over the forecast period. Increasing demand for hCG rapid test is attributed to rising incidence of gynaecological disorders and infertility rate across the globe.
Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-gb-607
Market Segmentation By Distribution Channels
On the basis of distribution channels, the market has been segmented into pharmacies, drugstores, gynaecology and fertility clinics, online sales and hypermarkets & supermarkets. Drugstores followed by pharmacies are the most preferred medium of distribution of fertility and pregnancy rapid test kits. However, increasing consumer preference for online sales channel which provides mail order requests, are expected to impart significant competition to these traditional channels in some of the regions such as North America and Western Europe.
The global fertility and pregnancy rapid test kits market has been segmented into seven major regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). In terms of value, the North America market has been estimated to dominate the global fertility and rapid test kits market in 2016, and is expected to expand at a CAGR of 3.6% over the forecast period. APEJ, MEA, and Latin America are estimated to be the fastest growing markets among regional markets. APEJ market is expected to witness highest CAGR of 5.1 % over the forecast period. In North America, mid-stream line indicator pregnancy rapid test device sub-segment is expected to grow at faster rate to reach the value US$ 125.2 Mn by 2026 end. Market in Western Europe is expected to exhibit healthy CAGR owing to growing acceptance of digital devices in the region.
Some of the key players in the global fertility and pregnancy rapid test kits market include Alere Inc., Quidel Corporation, Prestige Brands Holdings, Inc., Church & Dwight Co., Inc., bioMérieux SA, Geratherm Medical AG, Abbott Laboratories, Procter & Gamble Co., DCC Plc., Swiss Precision Diagnostics GmbH.